Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-02-02

FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Camber Pharmaceuticals to offer escitalopram oxalate as a generic antidepressant, expanding manufacturing and su…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram Oxalate (escitalopram oxalate)

Snippet

SUPPL AP for ESCITALOPRAM OXALATE (ESCITALOPRAM OXALATE)